Pattern of Visual Field Loss in Primary Angle-Closure Glaucoma Across Different Severity Levels.
Atalay Eray, Nongpiur Monisha E, Yap Sae Cheong, Wong Tina T, Goh David, Husain Rahat, Perera Shamira A, Aung Tin
AI Summary
This study found PACG causes worse superior visual field loss than inferior, with damage increasing with severity and being most pronounced nasally, aiding targeted monitoring.
Abstract
Purpose
To investigate the patterns of visual field (VF) defects in primary angle-closure glaucoma (PACG) across different severity levels and to assess hemifield differences within each severity level.
Design
Cross-sectional study.
Participants
Three hundred four patients diagnosed with PACG were recruited from glaucoma clinics at a Singapore hospital.
Methods
Point-wise total deviation values were recorded from the static automated perimetry (Swedish interactive threshold algorithm standard program 24-2; Humphrey model 750 [Carl Zeiss Meditec, Dublin, CA]) printouts. Patients were excluded if they had unreliable VFs (fixation losses >33% and false-positive responses >15%), had undergone only 10-2 VF testing, had VF defects not typical of glaucoma, or had undergone cataract extraction. Mild, moderate, and severe VF loss were defined by a mean deviation of -6.00 dB or more, -6.01 to -12.00 dB, and -12.01 dB or less, respectively. Each hemifield was divided into regions according to glaucoma hemifield test sectors. The average mean deviation (MD) of each region was obtained using total deviation values.
Main outcome measures
Between- and within-hemifield differences of the regions across the severity levels.
Results
After excluding ineligible cases, 249 patients with PACG were included in the analysis. Mean age of the patients was 65.7±8.6 years, with a 1:1 gender ratio. The number of patients who had mild, moderate, and severe VFs was 72 (28.9%), 78 (31.3%), and 99 (39.8%), respectively. For between-hemifield comparisons, all regions in the superior hemifield had worse MDs compared with their counterparts in the inferior hemifield across the severity spectrum. Likewise, for within-hemifield comparisons, MDs of the regions gradually worsened with increasing distance from the fixation point.
Conclusions
In this group of clinic-based PACG patients, the superior hemifield was found to be affected more severely than the inferior hemifield, and the differences between them increased with worsening disease severity. The damage was consistently more pronounced in the nasal area.
MeSH Terms
Shields Classification
Key Concepts6
A cross-sectional study of 249 patients with primary angle-closure glaucoma (PACG) from a Singapore hospital found that the superior hemifield had worse mean deviations (MDs) compared with their counterparts in the inferior hemifield across different severity levels of visual field loss.
In a cross-sectional study of 249 patients with primary angle-closure glaucoma (PACG), the differences in mean deviations between the superior and inferior hemifields increased with worsening disease severity.
A cross-sectional study of 249 patients with primary angle-closure glaucoma (PACG) demonstrated that visual field damage was consistently more pronounced in the nasal area across different severity levels.
In a cross-sectional study of 249 patients with primary angle-closure glaucoma (PACG), mean deviations (MDs) of the regions gradually worsened with increasing distance from the fixation point for within-hemifield comparisons.
A cross-sectional study of 249 patients with primary angle-closure glaucoma (PACG) defined mild visual field loss by a mean deviation of -6.00 dB or more, moderate by -6.01 to -12.00 dB, and severe by -12.01 dB or less.
A cross-sectional study of 249 patients with primary angle-closure glaucoma (PACG) found that 72 patients (28.9%) had mild, 78 patients (31.3%) had moderate, and 99 patients (39.8%) had severe visual field loss.
Related Articles5
Visual Field Progression Rates in Glaucoma: Frontloaded Versus Clinical Standard (Nonfrontloaded) SITA-Faster.
Observational StudyEndpoints and Design for Clinical Trials in USH2A-Related Retinal Degeneration: Results and Recommendations From the RUSH2A Natural History Study.
Clinical TrialLong-Term Blood Pressure Variability and Visual Field Progression in Glaucoma.
Cohort StudyArchetypal analysis quantifies changes in patterns of visual field loss in eyes with acute non-arteritic anterior ischaemic optic neuropathy.
Observational StudyPeripheral blood mononuclear cell respiratory function is associated with progressive glaucomatous vision loss.
Observational StudyIs this article assigned to the wrong chapter(s)? Let us know.